Evaluation of Perineural Catheterization Practices in Postoperative Orthopedic Surgery (Cathepos)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04011839|
Recruitment Status : Not yet recruiting
First Posted : July 9, 2019
Last Update Posted : October 8, 2019
Continuous peripheral nerve blocks are considered as the gold standard for postoperative analgesia in orthopaedic surgery (shoulder, knee, foot). These techniques are also used in chronic pain.
The main disadvantage of these techniques is that they can drive a more or less deep motor block that slows down the rehabilitation process. This disadvantage could be prevented (or minimized) by adapting the protocol for administering local anesthetics or by changing molecules (levobupivacaine 0.625 mg/ml instead of ropivacaine 2 mg/ml). There is no literature comparing the effectiveness of the sensory block and its impact on the motor block according to the administration protocol and/or the type of local anesthetics.
The main judgement criterion of such a study could be a composite criterion crossing the quality of the sensory block and the depth of the motor blockades, the ideal being to have a perfect sensory block without any motor block.
|Condition or disease||Intervention/treatment|
|Study Type :||Observational|
|Estimated Enrollment :||300 participants|
|Official Title:||Evaluation of Perineural Catheterization Practices in Postoperative Orthopedic Surgery|
|Estimated Study Start Date :||November 1, 2019|
|Estimated Primary Completion Date :||July 2020|
|Estimated Study Completion Date :||July 2020|
- Drug: Levobupivacaïne
Use of Levobupivacaïne instead ropivacaïne
- Comparison between sensory Block Quality and motor Block deep [ Time Frame: Day1 to Day 3 ]Composite score between 0 to 2 for Sensory Block and 0 to 2 for motor Block
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04011839
|Contact: Joel L'HERMITE, MDemail@example.com|